and recent immigrants from Western Africa than among other black patients. Such patients tend to have a "resistant" hypertension, with or without a susceptibility to hypokalemia, and typically have a good response to the addition of spironolactone or amiloride.
In clinics serving such populations, following Young's recommendations, especially in the case of older patients who have an increased coincidence of silent adrenal nodules, could lead to unnecessary invasive diagnostic procedures such as adrenal venous sampling. Therefore, clinical considerations, not just hormonal data, should guide the choice of further interventions. 
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To the Editor: McStay and Gordon report on a patient with antifreeze (presumably ethylene glycol) intoxication. The urine of their patient showed blue fluorescence under ultraviolet excitation. Fluorescein is a chromophore with a high quantum yield of fluorescence. Therefore, assessment of urine fluorescence was suggested in cases of suspected ethylene glycol intoxication. 1 The emission spectrum of fluorescein peaks at approximately 540 nm (green), and it is virtually absent below 500 nm (blue). 2 Thus, the deep-blue urine fluorescence described by McStay and Gordon presumably originated from a fluorophore other than fluorescein. A number of unknown fluorophores may be assumed to be the source of the fluorescence observed. For instance, a strong blue fluorescence was observed after excitation with ultraviolet light for certain ion-chelate complexes. 3 Only a strong green fluorescence points to fluorescein ingested with antifreeze. In a case of unusual fluorescence, as shown here, one should consider substances other than ethylene glycol as the source of intoxication. 
Superior Athletic Performance Two Decades after Cardiac Transplantation
To the Editor: Cardiac-transplant recipients have a severely reduced exercise capacity (defined as the maximum volume of oxygen consumed [VO 2 ]), in part because of chronotropic incompetence associated with cardiac denervation. 1 The upper limits of athletic performance and exercise capacity in the long term after cardiac transplantation are not clear. We report superior exercise capacity and athletic performance in a man two decades after he underwent cardiac transplantation. The patient underwent cardiac transplantation in August 1986, at 26 years of age. Other than a history of post-transplantation hypertension that was easily controlled with the use of calciumchannel blockers, he has had an uneventful course since the surgery, with no biopsy-proven or clinical evidence of rejection. He has been physically active, performing aerobic exercise 2 to 3 days per week. In October 2004, at 45 years of age, he participated in a 12-week exercise study at our center. His peak VO 2 after training (59 ml per kilogram of body weight per minute) was similar to the peak VO 2 achieved by age-matched, endurance-trained male athletes. 2 He had a rapid increase in heart rate from rest to peak exercise (change in heart rate, 81 beats per minute), and the rate returned toward baseline during recovery. His peak heart rate during exercise (177 beats per minute) was similar to the rate among agematched healthy persons. 3 Eighteen years after the transplantation, he completed a half-ironman triathlon in 6 hours and 28.7 minutes (finishing as the 454th of 558 competitors). A year later, he completed the same triathlon in 6 hours and 15.9 minutes (416th of 611 competitors). He also completed an Olympic distance triathlon in 3 hours and 2.1 minutes (75th of 126 competitors).
Cardiac-transplant recipients typically attain their highest peak VO 2 within the first year after surgery. 4 In contrast, our patient's experience illustrates that long-term aerobic training may result in a dramatic improvement in exercise capacity. One contributing factor is that his heartrate response to stress was similar to that in cardiac-transplant recipients who have functional evidence of cardiac reinnervation. 5 This patient's history shows that superior athletic performance can be achieved two decades after cardiac transplantation.
